Altimmune, Inc. (ALT)
2.785
-0.07
(-2.45%)
USD |
NASDAQ |
May 18, 15:41
Altimmune Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 37.36% |
| Madrigal Pharmaceuticals, Inc. | -30.32% |
| Amgen, Inc. | 21.02% |
| Verastem, Inc. | -196.0% |
| Karyopharm Therapeutics, Inc. | -63.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.63% |
| Return on Assets | -38.54% |
| Return on Invested Capital | -41.29% |
| Return on Net Operating Assets | -7.48K% |